In this study, we identified two chemokines (CCL17 and CCL22) that played an important role in activating the expression of GRP78. CCL17 and CCL22 as two of the major products of TAMs share a common receptor CCR4 that typically exists on the tumor cell surface [41]. Here, CCL22 is linked to neoplasm.